FDA Calls Kim Kardashian's Instagram Drug Endorsement 'Misleading'

Kim Kardashian will probably think twice next time she considers asking her 42 million Instagram followers to double-tap her prescription drug endorsements. The Food and Drug Administration sent a letter to the makers of Diclegis (a morning sickness drug she promoted last month) asking them to “stop ‘misbranding’ the drug or take it off the market.”

By “misbranding,” I think they mean “asking famous contoured faces to be photographed with their product under harsh lighting.”

Reports TMZ:

The problem … Kim sings the virtues but not the risks of the drug … something the FDA requires. The letter demands the company correct the problem by getting Kim to repost her endorsements with the proper warnings.

A rep for Diclegis also confirmed that, yes, Kim was paid for the post—but only the one time.

Imagine if Kim started posting images with captions like this:

Image via Instagram. Risks via Dicelgis.